141 related articles for article (PubMed ID: 10882843)
1. Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia.
Hori H; Ohmori O; Shinkai T; Kojima H; Okano C; Suzuki T; Nakamura J
Neuropsychopharmacology; 2000 Aug; 23(2):170-7. PubMed ID: 10882843
[TBL] [Abstract][Full Text] [Related]
2. [Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland].
Gałecki P; Pietras T; Szemraj J
Psychiatr Pol; 2006; 40(5):937-48. PubMed ID: 17217237
[TBL] [Abstract][Full Text] [Related]
3. Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia.
Akyol O; Yanik M; Elyas H; Namli M; Canatan H; Akin H; Yuce H; Yilmaz HR; Tutkun H; Sogut S; Herken H; Ozyurt H; Savas HA; Zoroglu SS
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):123-31. PubMed ID: 15610954
[TBL] [Abstract][Full Text] [Related]
4. Manganese superoxide dismutase (MnSOD: Ala-9Val) gene polymorphism may not be associated with schizophrenia and tardive dyskinesia.
Pae CU; Kim TS; Patkar AA; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
Psychiatry Res; 2007 Sep; 153(1):77-81. PubMed ID: 17582511
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
[TBL] [Abstract][Full Text] [Related]
6. Additive effect between quinine oxidoreductase gene (NQO1: Pro187Ser) and manganese superoxide dismutase gene (MnSOD: Ala-9Val) polymorphisms on tardive dyskinesia in patients with schizophrenia.
Pae CU
Psychiatry Res; 2008 Dec; 161(3):336-8. PubMed ID: 18977034
[TBL] [Abstract][Full Text] [Related]
7. Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with clinical phenotypes and tardive dyskinesia in schizophrenic patients.
Liu H; Wang C; Chen PH; Zhang BS; Zheng YL; Zhang CX; Meng HQ; Wang Y; Chen DC; Xiu MH; Kosten TR; Zhang XY
Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):692-6. PubMed ID: 20346996
[TBL] [Abstract][Full Text] [Related]
8. The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism.
Zhang Z; Zhang X; Hou G; Sha W; Reynolds GP
J Psychiatr Res; 2002; 36(5):317-24. PubMed ID: 12127599
[TBL] [Abstract][Full Text] [Related]
9. Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.
Hitzeroth A; Niehaus DJ; Koen L; Botes WC; Deleuze JF; Warnich L
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):664-72. PubMed ID: 17291655
[TBL] [Abstract][Full Text] [Related]
10. Manganese superoxide dismutase gene Ala-9Val polymorphism might be related to the severity of abnormal involuntary movements in Korean schizophrenic patients.
Kang SG; Choi JE; An H; Park YM; Lee HJ; Han C; Kim YK; Kim SH; Cho SN; Joe SH; Jung IK; Kim L; Lee MS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1844-7. PubMed ID: 18790709
[TBL] [Abstract][Full Text] [Related]
11. Meta-Analyses of Manganese Superoxide Dismutase Activity, Gene Ala-9Val Polymorphism, and the Risk of Schizophrenia.
Wang DF; Cao B; Xu MY; Liu YQ; Yan LL; Liu R; Wang JY; Lu QB
Medicine (Baltimore); 2015 Sep; 94(36):e1507. PubMed ID: 26356721
[TBL] [Abstract][Full Text] [Related]
12. [Functional polymorphism of manganese superoxide dismutase (MnSOD) gene correlates with schizophrenia in Polish population].
Gałecki P; Pietras T; Szemraj J; Florkowska K; Florkowski A; Zboralski K
Pol Merkur Lekarski; 2006 Mar; 20(117):329-32. PubMed ID: 16780268
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between tardive dyskinesia and the polymorphism of superoxide dismutase val9Ala and efficacy of Chaihu Taoren Capsules on it].
Su JM; Tan YL; Zhou DF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):700-3. PubMed ID: 17879532
[TBL] [Abstract][Full Text] [Related]
14. Interaction between polymorphisms of the dopamine D3 receptor and manganese superoxide dismutase genes in susceptibility to tardive dyskinesia.
Zhang ZJ; Zhang XB; Hou G; Yao H; Reynolds GP
Psychiatr Genet; 2003 Sep; 13(3):187-92. PubMed ID: 12960753
[TBL] [Abstract][Full Text] [Related]
15. Association of serotonin 2A receptor and lack of association of CYP1A2 gene polymorphism with tardive dyskinesia in a Turkish population.
Boke O; Gunes S; Kara N; Aker S; Sahin AR; Basar Y; Bagci H
DNA Cell Biol; 2007 Aug; 26(8):527-31. PubMed ID: 17688403
[TBL] [Abstract][Full Text] [Related]
16. Quinone oxidoreductase (NQO1) gene polymorphism (609C/T) may be associated with tardive dyskinesia, but not with the development of schizophrenia.
Pae CU; Yu HS; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH
Int J Neuropsychopharmacol; 2004 Dec; 7(4):495-500. PubMed ID: 15151706
[TBL] [Abstract][Full Text] [Related]
17. Association of the manganese superoxide dismutase gene Ala-9Val polymorphism with age of smoking initiation in male schizophrenia smokers.
Zhang XY; Rao WW; Yu Q; Yu Y; Kou C; Tan YL; Chen DC; Zuo L; Luo X; Soares JC
Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):243-9. PubMed ID: 26544677
[TBL] [Abstract][Full Text] [Related]
18. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes.
Zai CC; Tiwari AK; Basile V; de Luca V; Müller DJ; Voineskos AN; Remington G; Meltzer HY; Lieberman JA; Potkin SG; Kennedy JL
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):50-6. PubMed ID: 19778569
[TBL] [Abstract][Full Text] [Related]
20. Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics.
Nikoloff D; Shim JC; Fairchild M; Patten N; Fijal BA; Koch WH; MacPherson A; Flockhart D; Yoon YR; Yoon JS; Kim YH; Shin JG
Pharmacogenomics J; 2002; 2(6):400-7. PubMed ID: 12629505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]